TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent -> TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes
TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes Definition
A preparation of transforming growth factor-beta (TGF-beta)-resistant cytotoxic T-lymphocytes (CTL) reactive to Epstein-Barr virus (EBV) latent membrane proteins 1 and 2 (LMP 1 and 2) with potential antineoplastic activity. T lymphocytes are transduced with a retroviral vector expressing the dominant-negative mutant type II TGF-beta receptor, which blocks signaling by all three TGF-beta isoforms. These TGF-beta-resistant T-lymphocytes are exposed ex-vivo to dendritic cells (DCs) transfected with a replication-deficient adenovirus encoding EBV LMP; subsequent exposure to LMP1- or LMP2-expressing lymphoblastoid cell lines is used to expand the CTL. Administered to patients with EBV-positive tumors, TGF-beta-resistant LMP-specific CTL target LMP-positive cells, which may result in a specific CTL response, followed by cell lysis and inhibition of tumor cell proliferation. Tumor-expressed TGF-beta inhibits T lymphocyte activation and expansion.
TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes Synonyms
TGF-beta-Resistant LMP-Specific Cytotoxic T-Lymphocytes, TGF-beta-Resistant LMP-Specific CTLs
Terms in TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.